Literature DB >> 8012696

Adenosine A2B-receptor-mediated cyclic AMP accumulation in primary rat astrocytes.

M C Peakman1, S J Hill.   

Abstract

1. The effects of adenosine receptor agonists and antagonists on the accumulation of cyclic AMP have been investigated in primary cultures of rat astrocytes. 2. Adenosine A2-receptor stimulation caused a concentration-dependent increase in the accumulation of [3H]-cyclic AMP in cells prelabelled with [3H]-adenine. The rank order of agonist potencies was 5'-N-ethylcarboxamidoadenosine (NECA; EC50 = 1 microM) > adenosine (EC50 = 5 microM) > 2-chloroadenosine (EC50 = 20 microM) >> CGS 21680 (EC50 > 10 microM). The presence of 0.5 microM dipyridamole, an adenosine uptake blocker, had no effect on the potency of adenosine. 3. The response to 10 microM NECA was antagonized in a concentration-dependent manner by the non-selective adenosine receptor antagonists, xanthine amine congener (apparent KD = 12 nM), PD 115,199 (apparent KD = 134 nM) and 8-phenyltheophylline (apparent KD = 126 nM). However, the A1-receptor-selective antagonist, 8-cyclopentyl-1,3-dipropylxanthine, had no significant effect on the responses to NECA or 2-chloroadenosine at concentrations up to 1 microM. 4. Stimulation of A1-receptors with the selective agonist, N6-cyclopentyladenosine, did not alter the basal accumulation of [3H]-cyclic AMP but inhibited a forskolin-mediated elevation of [3H]-cyclic AMP accumulation by a maximal value of 42%. This inhibition was fully reversed in the presence of 0.1 microM, 8-cyclopentyl-1,3-dipropylxanthine. 5. The time course for NECA-mediated [3H]-cyclic AMP accumulation was investigated. The results suggest that there is a substantial efflux of cyclic AMP from the cells in addition to the rapid and sustained elevation of intracellular cyclic AMP (5 fold over basal) which was also observed. 6. These data indicate that rat astrocytes in primary culture express an A2B-adenosine receptor coupled positively to adenylyl cyclase. Furthermore, the presence of A1-receptors negatively coupled to adenylyl cyclase appears to have no significant effect on the A2B-receptor-mediated cyclic AMP responses to NECA and 2-chloroadenosine.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8012696      PMCID: PMC1910019          DOI: 10.1111/j.1476-5381.1994.tb14043.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  41 in total

1.  Adenosine regulates via two different types of receptors, the accumulation of cyclic AMP in cultured brain cells.

Authors:  D van Calker; M Müller; B Hamprecht
Journal:  J Neurochem       Date:  1979-11       Impact factor: 5.372

2.  Regulation of adenosine 3' :5'-monophosphate efflux from rat glioma cells in culture*.

Authors:  B J Doore; M M Bashor; N Spitzer; R C Mawe; M H Saier
Journal:  J Biol Chem       Date:  1975-06-10       Impact factor: 5.157

3.  Regulation of adenosine 3':5'-monophosphate efflux from animal cells.

Authors:  M J Rindler; M M Bashor; N Spitzer; M H Saier
Journal:  J Biol Chem       Date:  1978-08-10       Impact factor: 5.157

4.  The cyclic AMP system of human brain.

Authors:  T Kodama; Y Matsukado; H Shimizu
Journal:  Brain Res       Date:  1973-02-14       Impact factor: 3.252

5.  Characteristics of the beta 1-and beta 2-adrenergic-sensitive adenylate cyclases in glial cell primary cultures and their comparison with beta 2-adrenergic-sensitive adenylate cyclase of meningeal cells.

Authors:  C Ebersolt; M Perez; G Vassent; J Bockaert
Journal:  Brain Res       Date:  1981-05-25       Impact factor: 3.252

6.  Subclasses of adenosine receptors in the central nervous system: interaction with caffeine and related methylxanthines.

Authors:  J W Daly; P Butts-Lamb; W Padgett
Journal:  Cell Mol Neurobiol       Date:  1983-03       Impact factor: 5.046

7.  Neuronal, glial and meningeal localizations of neurotransmitter-sensitive adenylate cyclases in cerebral cortex of mice.

Authors:  C Ebersolt; M Perez; J Bockaert
Journal:  Brain Res       Date:  1981-05-25       Impact factor: 3.252

8.  Inhibition of brain adenylate cyclase by A1 adenosine receptors: pharmacological characteristics and locations.

Authors:  C Ebersolt; J Premont; A Prochiantz; M Perez; J Bockaert
Journal:  Brain Res       Date:  1983-05-09       Impact factor: 3.252

9.  Salmeterol, a long-acting beta 2-adrenoceptor agonist mediating cyclic AMP accumulation in a neuronal cell line.

Authors:  K E McCrea; S J Hill
Journal:  Br J Pharmacol       Date:  1993-10       Impact factor: 8.739

10.  Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue.

Authors:  K D McCarthy; J de Vellis
Journal:  J Cell Biol       Date:  1980-06       Impact factor: 10.539

View more
  24 in total

1.  Characterization of the human brain putative A2B adenosine receptor expressed in Chinese hamster ovary (CHO.A2B4) cells.

Authors:  S P Alexander; J Cooper; J Shine; S J Hill
Journal:  Br J Pharmacol       Date:  1996-11       Impact factor: 8.739

Review 2.  Cell-cell signaling in the neurovascular unit.

Authors:  Josephine Lok; Punkaj Gupta; Shuzhen Guo; Woo Jean Kim; Michael J Whalen; Klaus van Leyen; Eng H Lo
Journal:  Neurochem Res       Date:  2007-04-25       Impact factor: 3.996

Review 3.  Adenosine receptors as therapeutic targets.

Authors:  Kenneth A Jacobson; Zhan-Guo Gao
Journal:  Nat Rev Drug Discov       Date:  2006-03       Impact factor: 84.694

Review 4.  Purinoceptors on neuroglia.

Authors:  Alexei Verkhratsky; Alexei Verkhrasky; Oleg A Krishtal; Geoffrey Burnstock
Journal:  Mol Neurobiol       Date:  2009-03-13       Impact factor: 5.590

Review 5.  Physiology of Astroglia.

Authors:  Alexei Verkhratsky; Maiken Nedergaard
Journal:  Physiol Rev       Date:  2018-01-01       Impact factor: 37.312

6.  The A2B adenosine receptor protects against inflammation and excessive vascular adhesion.

Authors:  Dan Yang; Ying Zhang; Hao G Nguyen; Milka Koupenova; Anil K Chauhan; Maria Makitalo; Matthew R Jones; Cynthia St Hilaire; David C Seldin; Paul Toselli; Edward Lamperti; Barbara M Schreiber; Haralambos Gavras; Denisa D Wagner; Katya Ravid
Journal:  J Clin Invest       Date:  2006-07       Impact factor: 14.808

7.  Adenosine receptor-induced cyclic AMP generation and inhibition of 5-hydroxytryptamine release in human platelets.

Authors:  J A Cooper; S J Hill; S P Alexander; P C Rubin; E H Horn
Journal:  Br J Clin Pharmacol       Date:  1995-07       Impact factor: 4.335

Review 8.  Adenosine signaling and function in glial cells.

Authors:  D Boison; J-F Chen; B B Fredholm
Journal:  Cell Death Differ       Date:  2009-09-18       Impact factor: 15.828

Review 9.  Adenosine kinase: exploitation for therapeutic gain.

Authors:  Detlev Boison
Journal:  Pharmacol Rev       Date:  2013-04-16       Impact factor: 25.468

10.  Adenosine A1 receptor-mediated changes in basal and histamine-stimulated levels of intracellular calcium in primary rat astrocytes.

Authors:  M C Peakman; S J Hill
Journal:  Br J Pharmacol       Date:  1995-07       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.